Blog

The consumer advocacy group, Public Citizen, has filed a federal complaint against the U.S. Food and Drug Administration (FDA) to have the higher dose of the Alzheimer’s drug, Aricept, taken off the market because of the risk of fatal complications. The group made the first request 15 months ago and […]

U.S. News and World Report is revisiting a topic that needs to be revisited – the huge number of medical errors that harm and kill patients. The in-depth news report starts with a lesson presented to students at the University of Buffalo, New York, about an 88-year-old woman who was […]

You can buy almost anything on eBay, right? Even transvaginal mesh implants that have been taken off the market. DrugWatch reports that the Bard Avaulta polypropylene mesh has shown up on an eBay auction, including a Plus Posterior mesh. The price? $50. You can buy two Anterior Support System products […]

In December, at the Joint meeting of the Reproductive Health Drugs Advisory Committee and the Drug Safety and Risk Management Advisory Committee of the Food and Drug Administration, oral contraceptives containing drospirenone, approved since 2001, were discussed in detail. Drospirenone is a form of progestin, a synthetic hormone which is […]

Have you ever wondered how risky and dangerous drugs make it to market under the watchful eye of the U.S. Food and Drug Administration, charged with the responsibility of making sure they are safe and effective before they are released? The Journal of the American Medical Association tackles that question […]

It is one of the lesser known transvaginal meshes. Coloplast will now become the sixth multidistrict litigation consolidated and the fifth to be heard in the Southern District of West Virginia. The Judicial Panel on Multidistrict Litigation (JPML) on August 6 ordered at least 24 Coloplast federal lawsuits (MDL No. […]

AstraZeneca has agreed to pay $26 million to settle litigation involving the atypical antipsychotic, Seroquel. The South Carolina Attorney General had been after the company to reimburse state taxpayers for the off-label use of Seroquel. The company, along with other drugmakers, had challenged states that hire product liability attorneys on contingency […]

Imagine having a surgery that’s gone terribly wrong, only to discover – too late – that the doctors used a medical device its manufacturer knew could be dangerous, and worse, one that snuck right past the Food and Drug Administration (FDA). Couldn’t happen in this country? Wrong. More than 1,000 […]

Physicians from American University in Lebanon published a case report regarding Pradaxa (dabigatran etexilate) that was published in the July 28, 2012, edition of the Journal of Thrombosis and Thrombolysis.  In this article, the authors wrote about an 85 year old patient who developed shortness of breath, anemia, and white […]

Virtually all Rejuvenate and ABG II patients have received notice from their doctor that the devices have been recalled. These patients are all now faced with the prospect of a painful and risky revision surgery. Rejuvenate and ABG II victims can basically be placed into three categories. I know. I’ve […]